| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 辅料药(元) | 241,110,539.52 | 428,235,161.08 | 213,917,874.55 | 299,461,000.70 | 248,895,504.63 |
| 药品(元) | 1,672,519,179.69 | 3,837,757,087.44 | 1,925,896,990.05 | - | 2,040,151,215.59 |
| 药械智慧供应链(元) | 111,648,119.63 | 256,558,999.84 | 433,156,463.33 | 777,335,075.12 | 450,823,154.72 |
| 医疗器械(元) | 117,821,653.24 | 331,374,506.47 | 179,852,679.47 | 343,897,969.06 | 172,484,763.02 |
| 低分子量肝素钙注射液(元) | - | - | - | 176,066,018.44 | - |
| 血必净注射液(元) | - | - | - | 935,405,185.86 | - |
| 盐酸莫西沙星氯化钠注射液(元) | - | - | - | 159,475,279.56 | - |
| 依诺肝素钠注射液(元) | - | - | - | 129,839,189.71 | - |
| 原料药(元) | - | - | - | 149,799,406.63 | - |
| 中药配方颗粒(元) | - | - | - | 2,668,680,449.98 | - |
| 其他(元) | 44,853,548.18 | 87,198,794.74 | 42,144,262.79 | 142,807,353.65 | 83,879,184.41 |
| 营业成本(元) | |||||
| 辅料药(元) | 158,742,639.96 | 286,119,432.97 | 141,993,054.58 | - | 197,907,379.81 |
| 药品(元) | 593,501,708.67 | 1,320,800,627.05 | 676,789,006.92 | - | 721,500,912.75 |
| 药械智慧供应链(元) | 89,299,522.48 | 200,553,632.41 | 399,895,029.80 | 628,140,567.59 | 340,220,046.77 |
| 医疗器械(元) | 63,318,908.61 | 182,486,691.05 | 101,173,098.44 | - | 98,896,873.41 |
| 低分子量肝素钙注射液(元) | - | - | - | - | - |
| 血必净注射液(元) | - | - | - | 157,867,074.94 | - |
| 盐酸莫西沙星氯化钠注射液(元) | - | - | - | - | - |
| 依诺肝素钠注射液(元) | - | - | - | - | - |
| 原料药(元) | - | - | - | - | - |
| 中药配方颗粒(元) | - | - | - | 1,057,794,831.47 | - |
| 其他(元) | 36,258,901.47 | 70,053,610.80 | 37,143,415.97 | - | 51,318,290.41 |
| 毛利(元) | |||||
| 辅料药(元) | 82,367,899.56 | 142,115,728.11 | 71,924,819.97 | - | 50,988,124.82 |
| 药品(元) | 1,079,017,471.02 | 2,516,956,460.39 | 1,249,107,983.13 | - | 1,318,650,302.84 |
| 药械智慧供应链(元) | 22,348,597.15 | 56,005,367.43 | 33,261,433.53 | 149,194,507.53 | 110,603,107.95 |
| 医疗器械(元) | 54,502,744.63 | 148,887,815.42 | 78,679,581.03 | - | 73,587,889.61 |
| 低分子量肝素钙注射液(元) | - | - | - | - | - |
| 血必净注射液(元) | - | - | - | 777,538,110.92 | - |
| 盐酸莫西沙星氯化钠注射液(元) | - | - | - | - | - |
| 依诺肝素钠注射液(元) | - | - | - | - | - |
| 原料药(元) | - | - | - | - | - |
| 中药配方颗粒(元) | - | - | - | 1,610,885,618.51 | - |
| 其他(元) | 8,594,646.71 | 17,145,183.94 | 5,000,846.82 | - | 32,560,894.00 |
| 毛利率(%) | |||||
| 辅料药(%) | 34.16 | 33.19 | 33.62 | - | 20.49 |
| 药品(%) | 64.51 | 65.58 | 64.86 | - | 64.63 |
| 药械智慧供应链(%) | 20.02 | 21.83 | 7.68 | 19.19 | 24.53 |
| 医疗器械(%) | 46.26 | 44.93 | 43.75 | - | 42.66 |
| 低分子量肝素钙注射液(%) | - | - | - | - | - |
| 血必净注射液(%) | - | - | - | 83.12 | - |
| 盐酸莫西沙星氯化钠注射液(%) | - | - | - | - | - |
| 依诺肝素钠注射液(%) | - | - | - | - | - |
| 原料药(%) | - | - | - | - | - |
| 中药配方颗粒(%) | - | - | - | 60.36 | - |
| 其他(%) | 19.16 | 19.66 | 11.87 | - | 38.82 |
| 收入构成(%) | |||||
| 辅料药(%) | 11.02 | 8.67 | 7.65 | 5.18 | 8.31 |
| 药品(%) | 76.44 | 77.67 | 68.91 | - | 68.09 |
| 药械智慧供应链(%) | 5.10 | 5.19 | 15.50 | 13.44 | 15.05 |
| 医疗器械(%) | 5.39 | 6.71 | 6.43 | 5.95 | 5.76 |
| 低分子量肝素钙注射液(%) | - | - | - | 3.04 | - |
| 血必净注射液(%) | - | - | - | 16.18 | - |
| 盐酸莫西沙星氯化钠注射液(%) | - | - | - | 2.76 | - |
| 依诺肝素钠注射液(%) | - | - | - | 2.25 | - |
| 原料药(%) | - | - | - | 2.59 | - |
| 中药配方颗粒(%) | - | - | - | 46.15 | - |
| 其他(%) | 2.05 | 1.76 | 1.51 | 2.47 | 2.80 |
| 毛利构成(%) | |||||
| 辅料药(%) | 6.61 | 4.93 | 5.00 | 0.00 | 3.21 |
| 药品(%) | 86.54 | 87.36 | 86.87 | - | 83.12 |
| 药械智慧供应链(%) | 1.79 | 1.94 | 2.31 | 5.88 | 6.97 |
| 医疗器械(%) | 4.37 | 5.17 | 5.47 | 0.00 | 4.64 |
| 低分子量肝素钙注射液(%) | - | - | - | 0.00 | - |
| 血必净注射液(%) | - | - | - | 30.64 | - |
| 盐酸莫西沙星氯化钠注射液(%) | - | - | - | 0.00 | - |
| 依诺肝素钠注射液(%) | - | - | - | 0.00 | - |
| 原料药(%) | - | - | - | 0.00 | - |
| 中药配方颗粒(%) | - | - | - | 63.48 | - |
| 其他(%) | 0.69 | 0.60 | 0.35 | 0.00 | 2.05 |